Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5256)
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
500
Price
$16.11
Total Value
$8.06K
Shares Held After
5,000
% of Holdings
9.1%
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
10,081
Price
$16.11
Total Value
$162.41K
Shares Held After
853,569
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,362
Price
$571.95
Total Value
$779.00K
Shares Held After
40,513
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,197
Price
$571.22
Total Value
$1.83M
Shares Held After
41,875
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,621
Price
$570.28
Total Value
$2.06M
Shares Held After
45,072
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
843
Price
$569.18
Total Value
$479.82K
Shares Held After
48,693
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
197
Price
$568.37
Total Value
$111.97K
Shares Held After
49,536
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$567.17
Total Value
$45.37K
Shares Held After
49,733
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$565.78
Total Value
$113.16K
Shares Held After
49,813
% of Holdings
0.4%
DANAHER CORP /DE/ (DHR)
SPOON ALAN G — Director
Shares
1,358
Price
$174.67
Total Value
$237.21K
Shares Held After
124,094
% of Holdings
1.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$714.13
Total Value
$1.43K
Shares Held After
17,503
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$712.09
Total Value
$712.09
Shares Held After
17,505
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$711.49
Total Value
$3.56K
Shares Held After
17,506
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$710.87
Total Value
$1.42K
Shares Held After
17,511
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
6
Price
$709.45
Total Value
$4.26K
Shares Held After
17,513
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
4
Price
$707.40
Total Value
$2.83K
Shares Held After
17,519
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
7
Price
$706.74
Total Value
$4.95K
Shares Held After
17,523
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
14
Price
$705.56
Total Value
$9.88K
Shares Held After
17,530
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
15
Price
$704.28
Total Value
$10.56K
Shares Held After
17,544
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
24
Price
$703.46
Total Value
$16.88K
Shares Held After
17,559
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
15
Price
$702.46
Total Value
$10.54K
Shares Held After
17,583
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$701.76
Total Value
$3.51K
Shares Held After
17,598
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
23
Price
$160.00
Total Value
$3.68K
Shares Held After
3,666
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
38
Price
$159.08
Total Value
$6.04K
Shares Held After
3,689
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
65
Price
$158.35
Total Value
$10.29K
Shares Held After
3,727
% of Holdings
1.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
106
Price
$157.45
Total Value
$16.69K
Shares Held After
3,792
% of Holdings
2.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
82
Price
$156.24
Total Value
$12.81K
Shares Held After
3,898
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
346
Price
$155.48
Total Value
$53.79K
Shares Held After
3,980
% of Holdings
8.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
288
Price
$154.38
Total Value
$44.46K
Shares Held After
4,326
% of Holdings
6.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
52
Price
$153.89
Total Value
$8.00K
Shares Held After
4,614
% of Holdings
1.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
25,000
Price
$31.70
Total Value
$792.55K
Shares Held After
30,547
% of Holdings
45.0%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
25,000
Price
$31.70
Total Value
$792.54K
Shares Held After
8,223
% of Holdings
75.2%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
9,750
Price
$44.22
Total Value
$431.14K
Shares Held After
37,500
% of Holdings
20.6%
908 Devices Inc. (MASS)
Kenneweg John — SVP, Sales & Product Marketing
Shares
7,787
Price
$6.83
Total Value
$53.19K
Shares Held After
76,039
% of Holdings
9.3%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,857
Price
$65.00
Total Value
$1.03M
Shares Held After
58,555
% of Holdings
21.3%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.16
Total Value
$41.59K
Shares Held After
3,072,000
% of Holdings
0.3%
CHEMED CORP (CHE)
MCNAMARA KEVIN J — Director
Shares
2,000
Price
$421.13
Total Value
$842.26K
Shares Held After
90,219
% of Holdings
2.2%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
22,000
Price
$10.05
Total Value
$221.03K
Shares Held After
1,078,391
% of Holdings
2.0%
Anika Therapeutics, Inc. (ANIK)
HENNEMAN JOHN B III — Director
Shares
5,000
Price
$14.66
Total Value
$73.32K
Shares Held After
54,871
% of Holdings
9.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
12,500
Price
$71.37
Total Value
$892.12K
Shares Held After
97,994
% of Holdings
11.3%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$33.40
Total Value
$300.56K
Shares Held After
81,389
% of Holdings
10.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
300
Price
$74.96
Total Value
$22.49K
Shares Held After
612,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,700
Price
$74.23
Total Value
$126.19K
Shares Held After
612,840
% of Holdings
0.3%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,100
Price
$73.14
Total Value
$226.73K
Shares Held After
614,540
% of Holdings
0.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,000
Price
$71.76
Total Value
$71.76K
Shares Held After
617,640
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,600
Price
$70.77
Total Value
$254.77K
Shares Held After
618,640
% of Holdings
0.6%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,300
Price
$69.54
Total Value
$368.56K
Shares Held After
622,240
% of Holdings
0.8%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
400
Price
$75.37
Total Value
$30.15K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
5,059
Price
$74.60
Total Value
$377.40K
Shares Held After
400
% of Holdings
92.7%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
10,358
Price
$73.74
Total Value
$763.80K
Shares Held After
5,459
% of Holdings
65.5%
Showing 3101–3150 of 5256 transactions (page 63 of 106)